MTEM logo

Molecular Templates (MTEM)

Profile

Full Name

Molecular Templates, Inc.

Ticker Symbol

MTEM

Exchange

NASDAQ

Country

United States

IPO

February 4, 2005

Indexes

Not included

Employees

62

Key Details

Price

$0.00(0.00%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$52.63M(+166.40% YoY)

Annual EPS

-$1.80(+92.71% YoY)

PE ratio

-

Next earnings date

May 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Nov 11, 22 Barclays
Overweight
May 27, 22 B of A Securities
Underperform
Mar 30, 22 Barclays
Overweight
Apr 21, 21 B of A Securities
Buy
Feb 1, 21 UBS
Neutral
Sep 8, 20 Jefferies
Buy
May 12, 20 Oppenheimer
Outperform
Mar 25, 20 Stifel
Buy
Feb 27, 20 Barclays
Overweight
Apr 29, 19 UBS
Buy

Institutional Ownership

  • What is the ticker symbol for Molecular Templates?
  • Does Molecular Templates pay dividends?
  • What sector is Molecular Templates in?
  • What industry is Molecular Templates in?
  • What country is Molecular Templates based in?
  • When did Molecular Templates go public?
  • Is Molecular Templates in the S&P 500?
  • Is Molecular Templates in the NASDAQ 100?
  • Is Molecular Templates in the Dow Jones?
  • When was Molecular Templates's last earnings report?
  • When does Molecular Templates report earnings?
  • Should I buy Molecular Templates stock now?

What is the ticker symbol for Molecular Templates?

The ticker symbol for Molecular Templates is NASDAQ:MTEM

Does Molecular Templates pay dividends?

No, Molecular Templates does not pay dividends

What sector is Molecular Templates in?

Molecular Templates is in the Healthcare sector

What industry is Molecular Templates in?

Molecular Templates is in the Biotechnology industry

What country is Molecular Templates based in?

Molecular Templates is headquartered in United States

When did Molecular Templates go public?

Molecular Templates's initial public offering (IPO) was on February 4, 2005

Is Molecular Templates in the S&P 500?

No, Molecular Templates is not included in the S&P 500 index

Is Molecular Templates in the NASDAQ 100?

No, Molecular Templates is not included in the NASDAQ 100 index

Is Molecular Templates in the Dow Jones?

No, Molecular Templates is not included in the Dow Jones index

When was Molecular Templates's last earnings report?

Molecular Templates's most recent earnings report was on Nov 13, 2024

When does Molecular Templates report earnings?

The next expected earnings date for Molecular Templates is May 15, 2025

Should I buy Molecular Templates stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page